Since its inception, innovation is at the heart of Frontier Biotech. Over the years, Frontier Biotech has built an extraordinarily talented R&D team with deep expertise and extensive experience in new drug development. Through the successful development and launch of Aikening ^®, Frontier Biotech has established a state-of-the-art platform in advancing long-acting peptide drug innovation, which lays a solid foundation for expanding our product portfolio and further strengthening Frontier Biotech’s global competence. With unique in-house capability in complex peptide synthesis, process optimization, scale-up, commercialization, and a GMP certified facility for API & DP manufacturing, Frontier Biotech is committed to partnering with innovators, domestic and international, in new drug development.